Episode 4 in the Cutting Edge Conversation series featured Dr. Mujeebur Rahuman, Dr. Holger von Moeller, and Dr. Fernando Huerta as they discuss about industry challenges and innovations surrounding Chemical, Manufacturing and Controls in the life sciences industry.

During the course of the webinar a variety of emerging topics regarding chemicals, manufacturing and controls were discussed. Presenters spoke about RNA based therapies, and biologics, with a focus on the clinical development process of these new methodologies. They examined Investigational New Drug submission, which is one of the bottlenecks facing industry professionals, and  discussed how to accelerate that process as a component of Good Manufacturing Practice. The presenters expanded upon current topics such as manufacturing and controls for vaccines as well as new formulation techniques and solid state crystal forms. The group Q&A session provided all attendees with an opportunity to question these experts on any of these topics.

Key Topics Include:

  • Emerging RNA based therapies, biologics, including clinical development
  • How to accelerate IND submission (GMP production)
  • Chemical, Manufacturing, and Controls for vaccines
  • Solid state crystal forms and new formulation techniques


SVP & Head
Chemical Development Solutions

Mujeebur Rahuman has two decades of expertise in handling NCE process development, CRAMS, generic API development, DMF filing, technology development, innovation and cGMP manufacturing projects.


In conjunction with his partner Dr. Bernhard Loll, Dr. Holger von Moeller founded moloX in 2012 to provide highly pure proteins for pharmaceutical, biochemical, biotechnological, and academic research.

Project Director
RISE Bioscience & Materials, SE

In late 2015 Fernando started a new adventure as Freelancer researcher and chemical information systems consultant. Fernando F. Huerta is now Researcher and Project Leader at RISE Bioscience & Materials, SE

Production Partner


Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, they transform your ideas into solutions for better health.


Their mission is to deliver excellence in structural biology to our clients. In long term partnerships they work with academic and industrial clients, providing pure proteins for research purposes as well as full service for structural biology projects.

Research Institutes of Sweden

Through international collaboration programmes with industry, academia and the public sector, RISE ensures the competitiveness of the Swedish business community on an international level and contribute to a sustainable society.

Additional Content From Scientist.com

Related Content